Third-generation cephalosporins programmed restriction in the context of an outbreak of AmpC β-lactamase-producing gram-negative bacilli in critical units: a real-life experience
Published 2021-11-18
How to Cite
Copyright (c) 2021 Patricio Favier, Carla Raffo, Diego Torres, Enrique Serio, Johanna Pérez, Ivana Primost, Rosa Luna, Liliana Kumar, Diego Pérez

This work is licensed under a Creative Commons Attribution 4.0 International License.
Abstract
Background: Programmed restriction (PR) of antimicrobials can selectively decrease the rate of infections by certain microorganisms. In this sense, AmpC β-lactamase-producing gram-negative bacilli (GNB-blaAmpC) are selected for the overuse of third generation cephalosporins (3GC). These bacteria also acquire genes and co-produce other β-lactamases, such as Nueva Delhi ones (GNB-blaNDM). Aim: To decrease the isolation rate of GNB-blaAmpC and GNB-blaNDM in cultures from ICU patients after a PR of 3GC. Methods: Quasi-experimental study, before (P1= 12 months) and after (P2= 12 months) a PR of 3GC in an adults´ hospital. The use of antibiotics was expressed as “percentage days of treatment (%DOT)” /100 beds occupied per day (100-BOD). The rates of GNB-blaAmpC and GNB-blaNDM were compared in blood cultures (BC), mini-bronchio alveolar lavages (mB) and urine cultures (UC) in the ICU. Results: In P2, 3GC consumption was 2.5% DOT/100-COD. There was a decrease in GNB-blaAmpC from BC (RR 0,48 [0,2-0,9] p<0,02) and mB (RR 0,52 [0,3-0,9] p<0,02), as well as of GNB-blaNDM from BC (RR 8,1 [1,6-39,4] p<0,00).
Conclusions: PR of 3GC was linked to the reduction of GNB-blaAmpC and GNB-blaNDM in BC, as well as GNB-blaAmpC in mB from ICU patients.